{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-122456","form_type":"8-K","ticker":"RGNX","cik":"0001590877","company_name":"REGENXBIO Inc.","filed_at":"2025-05-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.923255+00:00","generated_at":"2026-05-21T01:37:21.593211+00:00","sec_items":["1.01","2.03","7.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"REGENXBIO closes up to $250M royalty bond with HCRx; $150M funded, cash runway into early 2027","bullets":["Received $150M at closing; up to $250M total via three tranches, including $50M contingent on Zolgensma sales threshold by Apr 2027.","Royalty bond bears interest at 9.75% + 3-month SOFR (4.25% floor); repayment solely from royalties on Zolgensma, RGX-121, RGX-111, and NAV platform licensees.","Issued HCRx warrant for 268,096 shares at $14.92 (100% premium to 30-day VWAP), exercisable for 10 years.","Extends expected cash runway into early 2027, funding late-stage programs including RGX-121, RGX-202, and ABBV-RGX-314.","Retains future non-dilutive sources: potential Priority Review Voucher for RGX-121 and milestones from AbbVie and Nippon Shinyaku."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-122456","json":"https://secwatch.observer/filing/0001193125-25-122456.json","markdown":"https://secwatch.observer/filing/0001193125-25-122456.md","text":"https://secwatch.observer/filing/0001193125-25-122456.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590877/000119312525122456/0001193125-25-122456-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590877/000119312525122456/d31892d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T01:37:21.593211+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}